149 related articles for article (PubMed ID: 16958594)
1. A long and winding road: defining the biological role and clinical importance of paraoxonases.
James RW
Clin Chem Lab Med; 2006; 44(9):1052-9. PubMed ID: 16958594
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of paraoxonases: a brief review.
Draganov DI; La Du BN
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):78-88. PubMed ID: 14579013
[TBL] [Abstract][Full Text] [Related]
3. Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.
Farid AS; Horii Y
Lipids Health Dis; 2012 Jul; 11():92. PubMed ID: 22824324
[TBL] [Abstract][Full Text] [Related]
4. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
Khersonsky O; Tawfik DS
Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase and atherosclerosis-related cardiovascular diseases.
Chistiakov DA; Melnichenko AA; Orekhov AN; Bobryshev YV
Biochimie; 2017 Jan; 132():19-27. PubMed ID: 27771368
[TBL] [Abstract][Full Text] [Related]
6. The growing importance of PON1 in cardiovascular health: a review.
Macharia M; Hassan MS; Blackhurst D; Erasmus RT; Matsha TE
J Cardiovasc Med (Hagerstown); 2012 Jul; 13(7):443-53. PubMed ID: 22673025
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonases: metabolic role and pharmacological projection.
Moya C; Máñez S
Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):349-359. PubMed ID: 29404699
[TBL] [Abstract][Full Text] [Related]
8. The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3.
Taler-Verčič A; Goličnik M; Bavec A
Molecules; 2020 Dec; 25(24):. PubMed ID: 33348669
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
10. Dysfunctional High-density Lipoprotein: The Role of Myeloperoxidase and Paraoxonase-1.
Bacchetti T; Ferretti G; Carbone F; Ministrini S; Montecucco F; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2021; 28(14):2842-2850. PubMed ID: 32674726
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity.
Tavori H; Vaya J; Aviram M
Adv Exp Med Biol; 2010; 660():99-111. PubMed ID: 20221874
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences.
Aviram M; Rosenblat M
Curr Opin Lipidol; 2005 Aug; 16(4):393-9. PubMed ID: 15990587
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 in endothelial cells impairs vasodilation induced by arachidonic acid lactone metabolite.
Gilad D; Atiya S; Mozes-Autmazgin Z; Ben-Shushan RS; Ben-David R; Amram E; Tamir S; Chuyun D; Szuchman-Sapir A
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):386-393. PubMed ID: 30572120
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonases role in the prevention of cardiovascular diseases.
Rosenblat M; Aviram M
Biofactors; 2009; 35(1):98-104. PubMed ID: 19319852
[TBL] [Abstract][Full Text] [Related]
15. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities.
Draganov DI; Teiber JF; Speelman A; Osawa Y; Sunahara R; La Du BN
J Lipid Res; 2005 Jun; 46(6):1239-47. PubMed ID: 15772423
[TBL] [Abstract][Full Text] [Related]
16. On the physiological role(s) of the paraoxonases.
La Du BN; Aviram M; Billecke S; Navab M; Primo-Parmo S; Sorenson RC; Standiford TJ
Chem Biol Interact; 1999 May; 119-120():379-88. PubMed ID: 10421474
[TBL] [Abstract][Full Text] [Related]
17. HDL--associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development.
Aviram M
Pathophysiol Haemost Thromb; 2006; 35(1-2):146-51. PubMed ID: 16855361
[No Abstract] [Full Text] [Related]
18. Paraoxonases (PON1, PON2, PON3) analyses in vitro and in vivo in relation to cardiovascular diseases.
Aviram M; Rosenblat M
Methods Mol Biol; 2008; 477():259-76. PubMed ID: 19082953
[TBL] [Abstract][Full Text] [Related]
19. The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases.
Khersonsky O; Tawfik DS
J Biol Chem; 2006 Mar; 281(11):7649-56. PubMed ID: 16407305
[TBL] [Abstract][Full Text] [Related]
20. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
